Having experience in both pharma and biotech R&D, we are well aware of what it means to discover a hit and transform it into a drug. You can best benefit from this “insider” experience through our integrated drug discovery services built upon:
Focusing on the patient and the disease
Always focused on the patient and the disease, we aim to use human primary cells and disease tissue samples while applying disease-relevant test models/systems in profiling potential drug candidates. Strong emphasis is placed on translational science and the early creation of translational strategies for smooth transition of candidate molecules into the clinic.
Importance of addressing key questions early
Prior to embarking on the creation of a screening cascade, we critically assess the true decision-making questions and define what will be the key differentiators of the drug candidate. The screening cascade that follows is designed to address these key points as early as possible. This accelerates the progression of your project, but also helps decrease later stage attrition and allows efforts to be concentrated where they are most needed. Additionally it focuses the minds of our medicinal chemists as they seek to deliver your candidate molecule in record time.
We bring together the scientific vigour and energy of young researchers with the experience and deep knowledge of senior members of the Selvita/Fidelta team. Blending excellent academic and industrial know-how, we provide optimal solutions for our customers’ integrated drug discovery programs. We are well versed in establishing cross-functional multidisciplinary project teams, encompassing the necessary expertise and optimal man power needed to deliver fully integrated drug discovery projects